tetano
Editor, Senior Moderator
Int Immunopharmacol. 2020 Apr 16;84:106519. doi: 10.1016/j.intimp.2020.106519. [Epub ahead of print]
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment.
di Mauro Gabriella[SUP]1[/SUP], Cristina S[SUP]2[/SUP], Concetta R[SUP]2[/SUP], Francesco R[SUP]2[/SUP], Annalisa C[SUP]2[/SUP].
Author information
Abstract
The new coronavirus outbreak is an ongoing pandemic that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The new coronavirus SARS-Cov-2 belongs to the subfamily of β-coronaviruses and shares 79.5% of the genetic sequence of SARS-CoV, the causative agent of the epidemic that started in 2002 and ended in 2004. Considering the clinical impact of the new outbreak, it is highly important to study the potential responses of the human immune system during the SARS-CoV-2 infection as well as the role of virus-specific T cells and by B-lymphocytes. Moreover, specific data on the production of IgG and IgM is crucial to allow the rapid identification of the infection. In this paper we also described the importance of sensitive and specific rapid test for SARS-CoV-2. Indeed, this test represents an important immunological tool aimed at identifying the precise phase of the infection in order to undertake a more appropriate pharmacological treatment. Lastly, we provided an overview of pharmacological treatments aimed to reduce inflammatory processes underlying the infection and the need for the discovery of a new vaccine against SARS-CoV-2.
Copyright ? 2020 The Authors. Published by Elsevier B.V. All rights reserved.
KEYWORDS:
Human immune system; Outbreak; Pharmacological treatments; Rapid test; SARS-Cov-2 infection
PMID:32311668DOI:10.1016/j.intimp.2020.106519
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment.
di Mauro Gabriella[SUP]1[/SUP], Cristina S[SUP]2[/SUP], Concetta R[SUP]2[/SUP], Francesco R[SUP]2[/SUP], Annalisa C[SUP]2[/SUP].
Author information
Abstract
The new coronavirus outbreak is an ongoing pandemic that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The new coronavirus SARS-Cov-2 belongs to the subfamily of β-coronaviruses and shares 79.5% of the genetic sequence of SARS-CoV, the causative agent of the epidemic that started in 2002 and ended in 2004. Considering the clinical impact of the new outbreak, it is highly important to study the potential responses of the human immune system during the SARS-CoV-2 infection as well as the role of virus-specific T cells and by B-lymphocytes. Moreover, specific data on the production of IgG and IgM is crucial to allow the rapid identification of the infection. In this paper we also described the importance of sensitive and specific rapid test for SARS-CoV-2. Indeed, this test represents an important immunological tool aimed at identifying the precise phase of the infection in order to undertake a more appropriate pharmacological treatment. Lastly, we provided an overview of pharmacological treatments aimed to reduce inflammatory processes underlying the infection and the need for the discovery of a new vaccine against SARS-CoV-2.
Copyright ? 2020 The Authors. Published by Elsevier B.V. All rights reserved.
KEYWORDS:
Human immune system; Outbreak; Pharmacological treatments; Rapid test; SARS-Cov-2 infection
PMID:32311668DOI:10.1016/j.intimp.2020.106519